Company news

Verici DX PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Completion of Placing & WRAP to raise £8.75m

October 30, 2026

Holding(s) in Company

October 29, 2026

Holding(s) in Company

October 29, 2026

Holding(s) in Company

October 29, 2026

Holding(s) in Company

October 29, 2026

Result of General Meeting

October 27, 2026

Investor Presentation

October 26, 2026

PTRA test to be used in Kidney Transplant Tx Study

October 22, 2026

Launch of US Kidney Care National Plan

October 22, 2026

Holding(s) in Company

October 21, 2026

Holding(s) in Company

October 15, 2026

Holding(s) in Company

October 15, 2026

Holding(s) in Company

October 15, 2026

Holding(s) in Company

October 14, 2026

Holding(s) in Company

October 14, 2026

Holding(s) in Company

October 14, 2026

Holding(s) in Company

October 14, 2026

Capital Access Window - Verici Dx Plc

October 13, 2026

Result of WRAP Retail Offer

October 13, 2026

Completion of £8.75 million Fundraising

October 13, 2026

Holding(s) in Company

October 12, 2026

Posting of Circular & Notice of GM

October 9, 2026

WRAP Retail Offer for up to £250,000

October 9, 2026

Result of Placing

October 9, 2026

Close of Accelerated Bookbuild

October 9, 2026

Launch of Proposed Placing

October 8, 2026

Capital Access Window - Verici Dx PLC

October 1, 2026

Proposed Fundraise and Capital Access Window

September 30, 2026

Half-year Report

September 30, 2026

Q4 launch of TranscripTx™ genetic test

September 21, 2026

Certified Service Provider agreement with Olink®

August 11, 2026

Investor presentation

July 6, 2026

Final results for the year ended 31 December 2025

June 29, 2026

New York State clinical lab certification received

June 24, 2026

WRAP Retail Offer for up to £200,000

June 8, 2026

Result of Placing & raising gross proceeds c£2.5m

June 5, 2026

AMA grants additional CPT® Code for ProtegaTM

June 2, 2026

Clinical study validating PTRA test published

May 19, 2026

Positive Q1 Trading Update

April 16, 2026

Board Change

March 31, 2026

FY25 Trading Update

February 5, 2026

Agreement with BCBS of Illinois for Tutivia™

February 5, 2026

Completion of CAP accreditation audit

November 12, 2025

Provider Participation Agreement with Prime Health

November 6, 2025

Completion of ISO 27001 surveillance audit

November 3, 2025

Options revision & Grant of new share options

October 30, 2025

Board Changes

October 6, 2025

Update on Tutivia™ test adoption

October 6, 2025

Holding(s) in Company

October 1, 2025

Half-year Report

September 30, 2025

Older news releases →

Calls

The 5 newest of 13 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.